AzTrials
AzTrials

Leucodepletion of Packed RBCNCT06151977

Impact of Lecuofiltration of Packed Red Blood Cells on Different Hematological Parameters Measured by Advia 2120

An observational study of Leucodepletion of Packed RBC, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Parameters of lecuofiltration of packed Red blood cells. Read more about this study

Who is it for?
Ages 18 to 59 yearsHealthy volunteers can take part
Conditions the study is for
Leucodepletion of Packed RBC
How many people
500 participants
Where
No sites listed yet
Study dates
1 Jan 2024to 29 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 59 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Healthy donors

Who may be able to join

  • packed RBC ADIA2120

Who cannot join

  • Whole blood

Trial locations and contacts

No sites are listed yet.

Yasmin Mo Sayed, Res contact

01155456741

yasmeend4@gmail.com

Saher Ab Elgamal, Pro contact

01002342312

S.elgammal@med.aun.edu.eg

About this study

Parameters of lecuofiltration of packed Red blood cells.

Read the detailed description

Impact of lecuofiltration of packed Red blood cells on different hematological parameters measured by Advia 2120

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Impact of lecuofiltration of packed Red blood cells on different hematological parameters measured by Advia 2120

    Leucodepletion of packed RBC affects the different parameters of blood component as hemoglobin, platelets , WBCs and so on. Measurement will be done by ADIA2120 hematological analyzer by taking a sample from the packed RBC before and after leucodepletion to compare the difference in hematological parameters.

    Measured: From 1/1/ 2024 to 29/12/2024

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2023
  2. Study start1 Jan 2024 (estimated)
  3. Primary completion29 Dec 2024 (estimated)
  4. Study completion29 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06151977
Sponsor's protocol ID
Leucodepleted blood parameters
Status last verified
Nov 2023
First submitted
16 Nov 2023
Last updated
30 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Pandey P, Pande A, Setya D, Kumar P, Shanker A. Comparative Study for Measurement of Residual Leucocytes in Leucodepleted Red Blood Cells by Two Different Methods. Indian J Hematol Blood Transfus. 2020 Oct;36(4):740-744. doi: 10.1007/s12288-020-01325-5. Epub 2020 Aug 14.

    PubMed 33100719

Questions about this trial

What is this clinical trial studying?

An observational study of Leucodepletion of Packed RBC, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yasmin Mo Sayed, Res (01155456741, yasmeend4@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Impact of lecuofiltration of packed Red blood cells on different hematological parameters measured by Advia 2120 (time frame: From 1/1/ 2024 to 29/12/2024). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06151977, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in